Samantha Semenkow
Stock Analyst at Citigroup
(0.71)
# 3,849
Out of 4,876 analysts
43
Total ratings
25.71%
Success rate
-22.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $2.42 | -38.02% | 3 | May 27, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $17 → $13 | $1.57 | +728.03% | 3 | May 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.18 | +238.98% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $560.14 | +43.36% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $21.08 | +184.63% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $4.20 | +19.05% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $2.96 | +305.41% | 1 | Dec 2, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $27 → $31 | $21.78 | +42.33% | 2 | Aug 9, 2024 | |
| SANA Sana Biotechnology | Maintains: Buy | $8 → $15 | $2.81 | +433.81% | 2 | Aug 9, 2024 | |
| SNSE Sensei Biotherapeutics | Reinstates: Buy | $80 | $8.68 | +821.66% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.03 | +362.05% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.28 | +557.89% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $47.52 | +51.52% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $16.10 | +210.56% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $16.80 | +233.33% | 3 | Aug 9, 2023 |
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $2.42
Upside: -38.02%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $17 → $13
Current: $1.57
Upside: +728.03%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.18
Upside: +238.98%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $560.14
Upside: +43.36%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $21.08
Upside: +184.63%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.20
Upside: +19.05%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $2.96
Upside: +305.41%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $21.78
Upside: +42.33%
Sana Biotechnology
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $2.81
Upside: +433.81%
Sensei Biotherapeutics
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $8.68
Upside: +821.66%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.03
Upside: +362.05%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.28
Upside: +557.89%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $47.52
Upside: +51.52%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $16.10
Upside: +210.56%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $16.80
Upside: +233.33%